US Patent 9273106 FGF mutants with reduced proteolysis and aggregation

Patent 9273106 was granted and assigned to Amgen on March, 2016 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

March 1, 2016

Patent Application Number

14134482

Date Filed

December 19, 2013

Patent Citations Received

Patent Primary Examiner

Patent abstract

The invention provides FGF21 mutant polypeptides with reduced proteolysis and aggregation, pharmaceutical compositions comprising the same.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 9273106 FGF mutants with reduced proteolysis and aggregation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.